Dr. Xiaosong Meng

Dr. Xiaosong Meng received his undergraduate degree in Electrical Engineering prior to starting the MD/PhD program at NYU. His PhD work under the guidance of James Salzer focused on studying how Schwann cells interact with axons to promote myelin formation in the peripheral nervous system.

After graduating from medical school, he matched into Urology at NYU where he played a key role in building the NYU prostate MRI and MRI-US fusion-targeted prostate biopsy database which formed the basis for multiple projects throughout residency. He also gained significant experience with focal cryotherapy, which helped fuel his interest in focal therapy for prostate cancer. He then moved to Dallas where he completed his urologic oncology fellowship at UT Southwestern Medical Center.

He is currently an assistant professor and Dedman Family Scholar in Clinical Care in the Department of Urology at UT Southwestern Medical Center and treats patients with a variety of urologic malignancies (kidney, bladder, prostate, testis and penile). He has a clinical focus on prostate cancer and prostate cancer focal therapy. His affiliations include membership in the American Urological Association, the Endourological Society, the Focal Therapy Society, and the Society for Urologic Oncology. He offers robotic radical prostatectomy, transurethral ultrasound ablation (TULSA), and irreversible electroporation (IRE) as treatment options for patients with prostate cancer. Additionally, he offers transperineal prostate biopsies with the ExactVu micro-ultrasound platform. He is involved in multiple clinical trials at UTSW regarding prostate cancer including the CAPTAIN randomized clinical trial comparing surgery to ablation. His research focus involves methods of looking at cancer recurrence after focal therapy and optimizing patient selection for treatment.